| The modified box-counting method: analysis of some characteristic parameters S Buczkowski, S Kyriacos, F Nekka, L Cartilier Pattern Recognition 31 (4), 411-418, 1998 | 204 | 1998 |
| Morphological analysis of HI features. II. Wavelet-based multifractal formalism A Khalil, G Joncas, F Nekka, P Kestener, A Arnéodo The Astrophysical Journal Supplement Series 165 (2), 512, 2006 | 103 | 2006 |
| Physiologically based predictions of the impact of inhibition of intestinal and hepatic metabolism on human pharmacokinetics of CYP3A substrates F Fenneteau, P Poulin, F Nekka Journal of pharmaceutical sciences 99 (1), 486-514, 2010 | 74 | 2010 |
| An update on population pharmacokinetic analyses of vancomycin, part I: in adults A Aljutayli, A Marsot, F Nekka Clinical pharmacokinetics 59, 671-698, 2020 | 58 | 2020 |
| A model of growing vascular structures F Nekka, S Kyriacos, C Kerrigan, L Cartilier Bulletin of mathematical biology 58, 409-424, 1996 | 53 | 1996 |
| Neutrophil dynamics during concurrent chemotherapy and G-CSF administration: mathematical modelling guides dose optimisation to minimise neutropenia M Craig, AR Humphries, F Nekka, J Bélair, J Li, MC Mackey Journal of theoretical biology 385, 77-89, 2015 | 47 | 2015 |
| A modified box-counting method S Kyriacos, S Buczkowski, F Nekka, L Cartilier Fractals 2 (02), 321-324, 1994 | 47 | 1994 |
| Assessing drug distribution in tissues expressing P-glycoprotein through physiologically based pharmacokinetic modeling: model structure and parameters determination F Fenneteau, J Turgeon, L Couture, V Michaud, J Li, F Nekka Theoretical Biology and Medical Modelling 6, 1-13, 2009 | 44 | 2009 |
| A pharmacokinetic formalism explicitly integrating the patient drug compliance J Li, F Nekka Journal of pharmacokinetics and pharmacodynamics 34, 115-139, 2007 | 36 | 2007 |
| Distinct effects of amlodipine treatment on vascular elastocalcinosis and stiffness in a rat model of isolated systolic hypertension R Essalihi, ML Zandvliet, S Moreau, LA Gilbert, C Bouvet, C Lenoël, ... Journal of hypertension 25 (9), 1879-1886, 2007 | 35 | 2007 |
| Modeling testosterone circadian rhythm in hypogonadal males: effect of age and circannual variations M González-Sales, O Barrière, PO Tremblay, F Nekka, J Desrochers, ... The AAPS journal 18, 217-227, 2016 | 33 | 2016 |
| Intersection of triadic Cantor sets with their translates—I. Fundamental properties F Nekka, J Li Chaos, Solitons & Fractals 13 (9), 1807-1817, 2002 | 32 | 2002 |
| Transit and lifespan in neutrophil production: implications for drug intervention D Câmara De Souza, M Craig, T Cassidy, J Li, F Nekka, J Bélair, ... Journal of pharmacokinetics and pharmacodynamics 45, 59-77, 2018 | 23 | 2018 |
| Morphological analysis of HI features. I. Metric space technique A Khalil, G Joncas, F Nekka The Astrophysical Journal 601 (1), 352, 2004 | 22 | 2004 |
| Intersection of triadic Cantor sets with their translates. II. Hausdorff measure spectrum function and its introduction for the classification of Cantor sets J Li, F Nekka Chaos, Solitons & Fractals 19 (1), 35-46, 2004 | 22 | 2004 |
| Chaos, Solitons & GH Li, A Arneodo, F Nekka Fractals 22, 549, 2004 | 21 | 2004 |
| Peripheral link model as an alternative for pharmacokinetic–pharmacodynamic modeling of drugs having a very short elimination half-life J Laurin, F Donati, F Nekka, F Varin Journal of Pharmacokinetics and Pharmacodynamics 28, 7-25, 2001 | 21 | 2001 |
| Insights into the formation process of the retinal vasculature S Kyriacos, F Nekka, L Cartilier, P Vico Fractals 5 (04), 615-624, 1997 | 20 | 1997 |
| A Bayesian approach for the estimation of patient compliance based on the last sampling information O Barrière, J Li, F Nekka Journal of pharmacokinetics and pharmacodynamics 38, 333-351, 2011 | 18 | 2011 |
| Assessing drug distribution in tissues expressing P-glycoprotein using physiologically based pharmacokinetic modeling: identification of important model parameters through … F Fenneteau, J Li, F Nekka Journal of pharmacokinetics and pharmacodynamics 36, 495-522, 2009 | 18 | 2009 |
